Get started
Author

William Tan

Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease
2021 · Jonathan Wei Jie Lee, Damian Plichta, et al. · Cell Host & Microbe · 230
PDF
Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission
2019 · Kelly C. Cushing, William Tan, et al. · Alimentary Pharmacology & Therapeutics · 78
PDF
Longitudinal Trajectory of Fatigue With Initiation of Biologic Therapy in Inflammatory Bowel Diseases: A Prospective Cohort Study
2019 · Nienke Z Borren, William Tan, et al. · Journal of Crohn s and Colitis · 59
Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease
2017 · Nienke Z. Borren, Grace Conway, et al. · Inflammatory Bowel Diseases · 43
PDF
Prospective Systematic Intervention to Reduce Patient Exposure to Radiation During Pediatric Ureteroscopy
2013 · Paul J. Kokorowski, Jeanne S. Chow, et al. · The Journal of Urology · 43
Cancer risk in microscopic colitis: a retrospective cohort study
2019 · Alexander Levy, Nienke Z. Borren, et al. · BMC Gastroenterology · 35
PDF
Ileal or Colonic Histologic Activity Is Not Associated With Clinical Relapse in Patients With Crohn’s Disease in Endoscopic Remission
2020 · Anne B. Hu, William Tan, et al. · Clinical Gastroenterology and Hepatology · 29
Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS - Mutant Colorectal Cancers
2024 · Patrick Loi, Amy E. Schade, et al. · Cancer Discovery · 15
Assessment of Body Weight Changes in Patients with Inflammatory Bowel Diseases Initiating Biologic Therapy: A Prospective Cohort Study
2020 · Nienke Z. Borren, William Tan, et al. · Digestive Diseases and Sciences · 12
651 Test Characteristics and Predictive Value of Ultrasound as a Screening Test for Gu Anomalies Among Children Presenting With Uti
2013 · Caleb Nelson, Jeanne Chow, et al. · The Journal of Urology · 6
279 Combination Therapy Does Not Improve Clinical and Endoscopic Remission Rates With Vedolizumab or Ustekinumab in Crohn's Disease and Ulcerative Colitis
2020 · Anne Hu, Paulo G. Kotze, et al. · Gastroenterology · 3
Sa1861 – Impact of Biologic Therapy on Resolution of Fatigue Symptoms in Patients with Active Inflammatory Bowel Disease: A Prospective Cohort Study
2019 · Nienke Z. Borren, William Tan, et al. · Gastroenterology · 3
PDF
337 – Complete Histologic Normalization is Associated with Reduced Risk of Relapse Among Patients with Ulcerative Colitis in Complete Endoscopic Remission
2019 · Kelly C. Cushing, William Tan, et al. · Gastroenterology · 1
Insights into early-onset colorectal cancer from a single-nucleus RNA-seq atlas of colorectal cancer across the age continuum
2026 · Caroline B. M. Porter, Shane P. Murphy, et al. · Nature Medicine
PDF
Analytical validation of a 90-gene expression assay for pan-cancer tissue-of-origin classification in Southeast Asia.
2026 · Zhe Sing Sin, Fei Ying Yap, et al. · Journal of Clinical Oncology
PDF
15Defining transcriptional phenotypes and heterogeneity across biliary tract cancers and matched PDX models
2026 · Sharon Bader, Andrew Navia, et al. · The Oncologist
Data from Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers
2024 · Patrick Loi, Amy E. Schade, et al.
Supplementary Figure S5 from Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers
2024 · Patrick Loi, Amy E. Schade, et al.
Supplementary Figure S1 from Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers
2024 · Patrick Loi, Amy E. Schade, et al.
Supplementary Figure S6 from Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers
2024 · Patrick Loi, Amy E. Schade, et al.
Supplementary Figure S4 from Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers
2024 · Patrick Loi, Amy E. Schade, et al.
Supplementary Figure S7 from Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers
2024 · Patrick Loi, Amy E. Schade, et al.
Supplementary Figure S2 from Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers
2024 · Patrick Loi, Amy E. Schade, et al.
PDF
Supplementary Figure S3 from Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers
2024 · Patrick Loi, Amy E. Schade, et al.
Mo1870 ASSESSMENT OF BODY WEIGHT CHANGES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES INITIATING BIOLOGIC THERAPY: A PROSPECTIVE COHORT STUDY
2020 · Nynke Z. Borren, William Tan, et al. · Gastroenterology
Works count: 30
Citation count: 557
H-index: 9
I10-index: 9
Year
Topic
Type